Detalhe da pesquisa
1.
Benefit of [18F] FDG PET/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 50(3): 881-891, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301324
2.
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 49(3): 980-991, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468782
3.
Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma.
Eur Radiol
; 32(6): 3649-3660, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989842
4.
A Pairwise Meta-Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma.
Oncologist
; 24(4): 505-512, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782977
5.
Pretreatment anemia and survival in nasopharyngeal carcinoma.
Tumour Biol
; 37(2): 2225-31, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26358251
6.
Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
Tumour Biol
; 37(4): 4429-38, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26499947
7.
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy.
Tumour Biol
; 36(10): 8213-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25994571
8.
Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma.
BMC Cancer
; 15: 429, 2015 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26003145
9.
Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 115(5): 1291-1300, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462689
10.
Radiomics and dosiomics for predicting radiation-induced hypothyroidism and guiding intensity-modulated radiotherapy.
iScience
; 26(12): 108394, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047064
11.
Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma.
Oral Oncol
; 147: 106583, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837738
12.
Deep learning-based precise prediction and early detection of radiation-induced temporal lobe injury for nasopharyngeal carcinoma.
EClinicalMedicine
; 58: 101930, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090437
13.
Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort study.
EClinicalMedicine
; 63: 102202, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680944
14.
Role of postoperative chemoradiotherapy in head and neck cancer without positive margins or extracapsular extension: a propensity score-matching analysis.
Radiat Oncol
; 17(1): 180, 2022 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372901
15.
Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity-modulated radiotherapy era.
Cancer Med
; 11(4): 1109-1118, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953045
16.
Effect of Induction Chemotherapy in Nasopharyngeal Carcinoma: An Updated Meta-Analysis.
Front Oncol
; 10: 591205, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33489889
17.
Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer.
J Cancer
; 10(6): 1349-1357, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31031844
18.
External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
Cancer Commun (Lond)
; 38(1): 55, 2018 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30176932
19.
Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Oral Oncol
; 85: 8-14, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220323
20.
Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study.
Onco Targets Ther
; 10: 3853-3860, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28814884